The purpose of this study was to retrospectively explore the relationship between human epidermal growth factor receptor @ ( HER@ ) messenger RNA ( mRNA ) expression and efficacy in patients receiving trastuzumab plus docetaxel ( HT ) or trastuzumab emtansine ( T-DM@ ) .